vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $236.8M, roughly 1.0× CROSS COUNTRY HEALTHCARE INC). Tecnoglass Inc. runs the higher net margin — 10.6% vs -35.0%, a 45.7% gap on every dollar of revenue. On growth, Tecnoglass Inc. posted the faster year-over-year revenue change (2.4% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $11.4M). Over the past eight quarters, Tecnoglass Inc.'s revenue compounded faster (12.8% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
CCRN vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $245.3M |
| Net Profit | $-82.9M | $26.1M |
| Gross Margin | — | 40.0% |
| Operating Margin | -30.2% | 18.3% |
| Net Margin | -35.0% | 10.6% |
| Revenue YoY | -23.6% | 2.4% |
| Net Profit YoY | -2109.7% | -44.5% |
| EPS (diluted) | $-2.56 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $245.3M | ||
| Q3 25 | $250.1M | $260.5M | ||
| Q2 25 | $274.1M | $255.5M | ||
| Q1 25 | $293.4M | $222.3M | ||
| Q4 24 | $309.9M | $239.6M | ||
| Q3 24 | $315.1M | $238.3M | ||
| Q2 24 | $339.8M | $219.7M | ||
| Q1 24 | $379.2M | $192.6M |
| Q4 25 | $-82.9M | $26.1M | ||
| Q3 25 | $-4.8M | $47.2M | ||
| Q2 25 | $-6.7M | $44.1M | ||
| Q1 25 | $-490.0K | $42.2M | ||
| Q4 24 | $-3.8M | $47.0M | ||
| Q3 24 | $2.6M | $49.5M | ||
| Q2 24 | $-16.1M | $35.0M | ||
| Q1 24 | $2.7M | $29.7M |
| Q4 25 | — | 40.0% | ||
| Q3 25 | 20.4% | 42.7% | ||
| Q2 25 | 20.4% | 44.7% | ||
| Q1 25 | 20.0% | 43.9% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | 20.4% | 45.8% | ||
| Q2 24 | 20.8% | 40.8% | ||
| Q1 24 | 20.4% | 38.8% |
| Q4 25 | -30.2% | 18.3% | ||
| Q3 25 | -2.4% | 25.1% | ||
| Q2 25 | -2.1% | 24.0% | ||
| Q1 25 | -0.3% | 26.7% | ||
| Q4 24 | -1.1% | 28.0% | ||
| Q3 24 | 0.9% | 28.4% | ||
| Q2 24 | -5.7% | 23.3% | ||
| Q1 24 | 0.8% | 21.3% |
| Q4 25 | -35.0% | 10.6% | ||
| Q3 25 | -1.9% | 18.1% | ||
| Q2 25 | -2.4% | 17.3% | ||
| Q1 25 | -0.2% | 19.0% | ||
| Q4 24 | -1.2% | 19.6% | ||
| Q3 24 | 0.8% | 20.8% | ||
| Q2 24 | -4.7% | 15.9% | ||
| Q1 24 | 0.7% | 15.4% |
| Q4 25 | $-2.56 | $0.57 | ||
| Q3 25 | $-0.15 | $1.01 | ||
| Q2 25 | $-0.20 | $0.94 | ||
| Q1 25 | $-0.02 | $0.90 | ||
| Q4 24 | $-0.13 | $1.00 | ||
| Q3 24 | $0.08 | $1.05 | ||
| Q2 24 | $-0.47 | $0.75 | ||
| Q1 24 | $0.08 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $104.1M |
| Total DebtLower is stronger | — | $174.4M |
| Stockholders' EquityBook value | $322.8M | $713.1M |
| Total Assets | $449.0M | $1.3B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $104.1M | ||
| Q3 25 | $99.1M | $127.1M | ||
| Q2 25 | $81.2M | $140.9M | ||
| Q1 25 | $80.7M | $160.2M | ||
| Q4 24 | $81.6M | $137.5M | ||
| Q3 24 | $64.0M | $124.8M | ||
| Q2 24 | $69.6M | $129.5M | ||
| Q1 24 | $5.2M | $138.8M |
| Q4 25 | — | $174.4M | ||
| Q3 25 | — | $114.7M | ||
| Q2 25 | — | $110.6M | ||
| Q1 25 | — | $110.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $126.8M | ||
| Q2 24 | — | $144.7M | ||
| Q1 24 | — | $160.9M |
| Q4 25 | $322.8M | $713.1M | ||
| Q3 25 | $408.1M | $764.0M | ||
| Q2 25 | $412.2M | $736.0M | ||
| Q1 25 | $418.2M | $685.1M | ||
| Q4 24 | $419.0M | $631.2M | ||
| Q3 24 | $424.7M | $613.3M | ||
| Q2 24 | $433.3M | $574.8M | ||
| Q1 24 | $462.4M | $573.6M |
| Q4 25 | $449.0M | $1.3B | ||
| Q3 25 | $538.2M | $1.2B | ||
| Q2 25 | $553.8M | $1.2B | ||
| Q1 25 | $576.2M | $1.1B | ||
| Q4 24 | $589.3M | $1.0B | ||
| Q3 24 | $597.4M | $996.3M | ||
| Q2 24 | $602.9M | $942.5M | ||
| Q1 24 | $648.4M | $981.6M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $31.0M |
| Free Cash FlowOCF − Capex | $16.1M | $11.4M |
| FCF MarginFCF / Revenue | 6.8% | 4.7% |
| Capex IntensityCapex / Revenue | 0.9% | 8.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $31.0M | ||
| Q3 25 | $20.1M | $40.0M | ||
| Q2 25 | $4.2M | $17.9M | ||
| Q1 25 | $5.7M | $46.9M | ||
| Q4 24 | $24.2M | $61.1M | ||
| Q3 24 | $7.5M | $41.5M | ||
| Q2 24 | $82.4M | $34.5M | ||
| Q1 24 | $6.0M | $33.4M |
| Q4 25 | $16.1M | $11.4M | ||
| Q3 25 | $17.9M | $21.2M | ||
| Q2 25 | $2.3M | $-14.7M | ||
| Q1 25 | $3.8M | $16.5M | ||
| Q4 24 | $21.7M | $35.4M | ||
| Q3 24 | $6.3M | $17.8M | ||
| Q2 24 | $79.6M | $14.2M | ||
| Q1 24 | $3.8M | $23.6M |
| Q4 25 | 6.8% | 4.7% | ||
| Q3 25 | 7.2% | 8.2% | ||
| Q2 25 | 0.8% | -5.7% | ||
| Q1 25 | 1.3% | 7.4% | ||
| Q4 24 | 7.0% | 14.8% | ||
| Q3 24 | 2.0% | 7.5% | ||
| Q2 24 | 23.4% | 6.5% | ||
| Q1 24 | 1.0% | 12.2% |
| Q4 25 | 0.9% | 8.0% | ||
| Q3 25 | 0.9% | 7.2% | ||
| Q2 25 | 0.7% | 12.7% | ||
| Q1 25 | 0.6% | 13.7% | ||
| Q4 24 | 0.8% | 10.7% | ||
| Q3 24 | 0.4% | 9.9% | ||
| Q2 24 | 0.8% | 9.2% | ||
| Q1 24 | 0.6% | 5.1% |
| Q4 25 | — | 1.19× | ||
| Q3 25 | — | 0.85× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | 2.92× | 0.84× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | 2.23× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
